Maa: Israel
Kieli: englanti
Lähde: Ministry of Health
QUETIAPINE AS FUMARATE
INOVAMED LTD
N05AH04
TABLETS PROLONGED RELEASE
QUETIAPINE AS FUMARATE 150 MG
PER OS
Required
PHARMATHEN S.A., GREECE
QUETIAPINE
Quetiapine Inovamed SR is indicated for the treatment of Schizophrenia. Quetiapine Inovamed SR is effective in preventing relapse in stable schizophrenic patients who have been maintained on Quetiapine Inovamed SR. Quetiapine Inovamed SR is indicated for the treatment of moderate to severe manic episodes associated with bipolar disorder. Quetiapine Inovamed SR is indicated for the treatment of major depressive episodes in bipolar disorder. Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for preventing recurrence in bipolar disorder in patients whose manic, mixed or depressive episode has responded to quetiapine treatment, as monotherapy or in combination with lithium or sodium valproate. Quetiapine Inovamed SR is indicated for add-on treatment of major depressive episods in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy. Prior to initiating treatment, clinicians should consider the safety profile of Quetiapine Inovamed SR.
2020-11-02
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS (PREPARATIONS) - 1986 This medicine is dispensed without a doctor's prescription LEMOCIN LEMON LEMOCIN CHERRY LOZENGES ACTIVE INGREDIENTS AND THEIR QUANTITIES: Each lozenge contains: lidocaine 1 mg tyrothricin 4 mg cetrimonium bromide 2 mg Inactive ingredients and allergens: See section 2 under "Important information about some of this medicine’s ingredients" and section 6 "Additional information". READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE. This leaflet contains concise information about this medicine. If you have any further questions, consult your doctor or pharmacist. Use the medicine according to the instructions provided in the dosage section of this leaflet. Consult your pharmacist if you need further information. Contact your doctor if disease symptoms are worsening or do not improve after 5-7 days. 1. WHAT IS THIS MEDICINE INTENDED FOR? Lemocin is a lozenge for relief of severe sore throat and pain associated with oral infections. The medicine is intended for adults and children above the age of 12 years. THERAPEUTIC GROUP: Lemocin contains lidocaine (local anaesthetic), tyrothricin (antibiotic) and cetrimonium bromide (antiseptic). 2. BEFORE USING THIS MEDICINE DO NOT USE THIS MEDICINE IF: You are sensitive (allergic) to the active ingredients (lidocaine, tyrothricin and cetrimonium bromide) or to any of the other ingredients in this medicine (see section 6). SPECIAL WARNINGS ABOUT USING THIS MEDICINE BEFORE USING LEMOCIN, TELL YOUR DOCTOR/PHARMACIST IF: ● You have a sore throat accompanied by fever for several days, ● You have a cut or injury in the mucosal lining of the mouth or throat, ● The symptoms do not improve or persist for longer than 5-7 days, ● You have a sore throat accompanied by high fever, dizziness, vomiting or severe discomfort upon swallowing. Before using the medicine, inform your doctor/pharmacist if you have any disease or if you have previously experienced allergic reactions. Do n Lue koko asiakirja